AI Assistant
Blog
Pricing
Log In
Sign Up
DOP006 A multicentre cohort study to assess the safety of vedolizumab for inflammatory bowel disease
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
